【ChiCTR2500099134】Effect of an evidence-based assessment instrument to minimize the use of physical restraint in general adult ward settings in Hong Kong: A cluster randomized controlled trial
ChiCTR2500099134
尚未开始
/
/
/
2025-03-19
/
/
Nil
Effect of an evidence-based assessment instrument to minimize the use of physical restraint in general adult ward settings in Hong Kong: A cluster randomized controlled trial
Effect of an evidence-based assessment instrument to minimize the use of physical restraint in general adult ward settings in Hong Kong: A cluster randomized controlled trial
The objectives of this research are to evaluate the effect of the evidence-based assessment instrument to minimize the use of PR in general adult ward settings, and the process evaluation and satisfaction of the evidence-based assessment instrument when applying in general adult ward settings in Hong Kong.
整群随机分组
其它
A single blinded cluster randomized controlled trial will be conducted in a total of eight wards within the department of Medicine & Geriatrics (M&G), the department of Orthopaedics & Traumatology (O&T), and the Department of Surgery (SUR) from 8th April to 9th June 2025 at UCH. Two wards from O&T and SUR, along with four wards from M&G, will be randomly assigned using simple random sampling.
A single blinded cluster randomized controlled trial will be conducted as the patient does not know which group they are allocated.
Nil
/
932
/
2025-03-25
2025-06-09
/
Participants aged 18 or above and admitted to the general adult ward settings at the research sites within the hospital are eligible to participate in the study. All nurses who provide direct patient care, will be included for the process evaluation and satisfaction review.；
请登录查看For the clinical study, there are no exclusion criteria, as all patients are under treatment and care during hospitalization. Participation in the evaluation is voluntary for healthcare providers who wish to give feedback and participate in the survey.；
请登录查看United Christian Hospital, Hong Kong Hospital Authority
/
United Christian Hospital, Hong Kong Hospital Authority的其他临床试验
United Christian Hospital, Hong Kong Hospital Authority的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04